Results 291 to 300 of about 182,947 (342)
Some of the next articles are maybe not open access.
GROWTH HORMONE RELEASING FACTORS
Annual Review of Biochemistry, 1985PERSPECTIVES AND SUMMARy. . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 403 ISOLATION AND CHARACTERIZATION OF GRFs FROM TUMOR AND HYPOTHALAMIC TISSUE . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . 405 Tumor GRFs . .
Nicholas Ling+7 more
openaire +3 more sources
Growth Hormone Releasing Hormone and Growth Hormone Releasing Peptides
1995The regulation of growth hormone (GH) secretion in humans is a complex entity involving primary regulators and secondary modifiers that influence both the amount and pattern of GH release. The primary regulators are the hypothalamic hormones: somatostatin (SRIH) and growth hormone releasing hormone (GHRH).
Joseph A. Aloi+4 more
openaire +2 more sources
Independent effects of growth hormone releasing factor on growth hormone release and gene transcription [PDF]
The synthesis and secretion of growth hormone (GH) by the somatotropic cells of the anterior pituitary is under complex hormonal regulation. The hypothalamic peptides, growth hormone releasing factor (GHRF) and somatostatin, respectively stimulate and block GH release.
Michael G. Rosenfeld+6 more
openaire +2 more sources
Growth Hormone Release in Response to Growth Hormone-Releasing Hormone in Term and Preterm Neonates
Neonatology, 1989The growth hormone response to a single intravenous dose of human growth hormone-releasing hormone (GHRH) was examined in 23 healthy neonates (12 term and 11 preterm) aged 2–4 days. There were no significant increases in growth hormone concentrations at any point in time studied following GHRH administration in either group of new-borns. The mean basal
Luis A. Moret+5 more
openaire +3 more sources
Growth Hormone Releasing Hormone Receptor
Receptors and Channels, 2002Growth hormone releasing hormone receptor (GHRH-R) is a class II G protein-coupled receptor required for normal growth hormone (GH) synthesis and release from the pituitary, and for the normal growth and proliferation of somatotrophs within the pituitary.
openaire +3 more sources
The growth hormone-releasing hormone receptor
2001Publisher Summary This chapter describes growth hormone (GH) as a polypeptide secreted by the somatotroph cells of the anterior pituitary gland, is the primary stimulator of linear growth in vertebrates and is involved in the regulation of protein and fat metabolism.
Venita I. DeAlmeida, Kelly E. Mayo
openaire +3 more sources
The Journal of Clinical Endocrinology & Metabolism, 1990
Recent studies in the rat have shown that intracerebroventricular administration of CRH inhibited spontaneous pulsatile GH secretion and prevented GH-releasing hormone (GHRH)-induced GH release. We have studied the effect of CRH on GHRH-induced GH release in man.
Barbarino, Antonino+7 more
openaire +4 more sources
Recent studies in the rat have shown that intracerebroventricular administration of CRH inhibited spontaneous pulsatile GH secretion and prevented GH-releasing hormone (GHRH)-induced GH release. We have studied the effect of CRH on GHRH-induced GH release in man.
Barbarino, Antonino+7 more
openaire +4 more sources
Neuroendocrinology, 1989
The effects of opiate receptor antagonist naloxone on growth hormone (GH) release after growth hormone-releasing hormone (GHRH) administration were investigated, before or after feeding, at 13.00 h, in 20 obese women and in 10 normal women. When GHRH was administered to obese women before a meal at lunch time, the mean peak plasma GH levels were very ...
De Marinis, Laura+8 more
openaire +4 more sources
The effects of opiate receptor antagonist naloxone on growth hormone (GH) release after growth hormone-releasing hormone (GHRH) administration were investigated, before or after feeding, at 13.00 h, in 20 obese women and in 10 normal women. When GHRH was administered to obese women before a meal at lunch time, the mean peak plasma GH levels were very ...
De Marinis, Laura+8 more
openaire +4 more sources
Hormone and Metabolic Research, 1987
We administered growth-hormone releasing hormone (GHRH), clonidine or thyrotropin-releasing hormone (TRH) as intravenous boli each in three different randomized mornings to nine well-controlled Type 1 diabetic men and to six age-matched healthy men who served as controls.
GIAMPIETRO, OTTAVIO+7 more
openaire +5 more sources
We administered growth-hormone releasing hormone (GHRH), clonidine or thyrotropin-releasing hormone (TRH) as intravenous boli each in three different randomized mornings to nine well-controlled Type 1 diabetic men and to six age-matched healthy men who served as controls.
GIAMPIETRO, OTTAVIO+7 more
openaire +5 more sources
Journal of Endocrinological Investigation, 1991
In order to investigate the mechanisms by which gastrin cause GH release in humans we measured the GH response to pentagastrin alone (1.5 micrograms/kg/hour from 120 to 210 min) and following pretreatment with GHRH (GHRH 1-29,250 micrograms, iv at 0 min) in normal male subjects. Prior GHRH administration abolished the GH response to the second bolus of
J F Garcia-Rojas+5 more
openaire +3 more sources
In order to investigate the mechanisms by which gastrin cause GH release in humans we measured the GH response to pentagastrin alone (1.5 micrograms/kg/hour from 120 to 210 min) and following pretreatment with GHRH (GHRH 1-29,250 micrograms, iv at 0 min) in normal male subjects. Prior GHRH administration abolished the GH response to the second bolus of
J F Garcia-Rojas+5 more
openaire +3 more sources